Cytomegalovirus infection in solid-organ transplant recipients. research hub

HORUS-Cytomegalovirus Open Proof-of-concept Exploratory trial

This study looks at adults who have had an organ transplant and developed an infection called cytomegalovirus (CMV). Researchers want to see how different anti-rejection medicines, including everolimus and mycophenolic acid, affect virus levels in the blood over three weeks, helping doctors improve care for transplant patients.